NCT04411225View on ClinicalTrials.gov

Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

PHASE3RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

October 30, 2025

Conditions
Early Psychosis
Interventions
DRUG

Cannabidiol oral solution

Both the active drug (cannabidiol) and placebo will be in oral solution.

Trial Locations (2)

92093

RECRUITING

UC San Diego, La Jolla

RECRUITING

University of California, San Diego, San Diego

Sponsors
All Listed Sponsors
collaborator

Center for Medicinal Cannabis Research

OTHER

lead

University of California, San Diego

OTHER